EDITORIAL
Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors A Challenge to Improve Usual Care
Article, see p 1193 Downloaded from http://circ.ahajournals.org/ by guest on September 25, 2017
T
Peter W.F. Wilson, MD David Gagnon, MD, PhD
he article by Pagidipati et al1 in this issue of Circulation reports the implications of inadequate risk factor treatment and control in adults with type 2 diabetes mellitus (T2DM) enrolled in a large multinational clinical trial that evaluated the cardiovascular disease (CVD) safety of an oral dipeptidyl peptidase-4 inhibitor medication that lowers blood glucose. In this post hoc analysis, the authors assessed at baseline the risk factor control for aspirin use, smoking, blood pressure
Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors A Challenge to Improve Usual Care
Article, see p 1193 Downloaded from http://circ.ahajournals.org/ by guest on September 25, 2017
T
Peter W.F. Wilson, MD David Gagnon, MD, PhD
he article by Pagidipati et al1 in this issue of Circulation reports the implications of inadequate risk factor treatment and control in adults with type 2 diabetes mellitus (T2DM) enrolled in a large multinational clinical trial that evaluated the cardiovascular disease (CVD) safety of an oral dipeptidyl peptidase-4 inhibitor medication that lowers blood glucose. In this post hoc analysis, the authors assessed at baseline the risk factor control for aspirin use, smoking, blood pressure
